Day: February 4, 2026

                To Nasdaq Copenhagen A/S4 February 2026Nykredit today announces the Annual Reports for 2025 of: Nykredit A/S, CVR no 12 71 92 48Nykredit Realkredit A/S, CVR no 12 71 92 80Nykredit Bank A/S, CVR no 10 51 96 08Totalkredit A/S, CVR no 21 83 22 78Spar Nord Bank A/S, CVR no 13 73 75 84                 Michael Rasmussen, Group Chief Executive, comments on the Nykredit Group’s financial results:Today, we can present the Nykredit Group’s best financial results ever for the fifth year running, with a profit after tax for the year of DKK 12.4 billion. This confirms the fact that Nykredit has never been stronger. As we’re a customer-owned Group, our success benefits our customers, and in 2025, the Nykredit Group returned a total of DKK 3.0 billion to customers. That’s how it should be when our...

OSE’s technology modernization strengthens Japan’s position as a leading global derivatives marketExpands Nasdaq’s comprehensive technology partnership across Japan’s financial services ecosystem TOKYO and NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that Japan Exchange Group’s Osaka Exchange (OSE) has selected Nasdaq’s advanced Eqlipse Trading and Market Surveillance technology platforms for its next-generation derivatives infrastructure. This strategic technology partnership represents a significant step forward in OSE’s modernization journey, positioning Japan’s derivatives market for enhanced global competitiveness and future growth opportunities. Ryusuke Yokoyama, President & CEO of OSE, said: “I am very pleased that we have selected Nasdaq...

Bagsværd, Denmark, 4 February 2026 – Today, Novo Nordisk A/S has issued its 2025 annual report. The report is available here: https://www.novonordisk.com/investors/annual-report.html and is attached in iXBRL format. Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries. Novo Nordisk’s B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com, Facebook, Instagram,...

Empower BP is a landmark global pivotal study evaluating the safety and effectiveness of the implantable ARC-IM® System to address blood pressure instability after spinal cord injury (SCI) Blood pressure instability is a key unmet need after SCI, with a significant impact on cardiovascular health and quality of life The first participant was enrolled at Craig Hospital in Denver, Colorado, USAEINDHOVEN, the Netherlands, Feb. 04, 2026 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces the enrollment of the first participant in Empower BP, a global pivotal study assessing the safety and effectiveness of the investigational ARC-IM® System in managing symptomatic blood...

                To Nasdaq Copenhagen A/S4 February 2026Nykredit today announces the Annual Reports for 2025 of: Nykredit A/S, CVR no 12 71 92 48Nykredit Realkredit A/S, CVR no 12 71 92 80Nykredit Bank A/S, CVR no 10 51 96 08Totalkredit A/S, CVR no 21 83 22 78Spar Nord Bank A/S, CVR no 13 73 75 84                 Michael Rasmussen, Group Chief Executive, comments on the Nykredit Group’s financial results:Today, we can present the Nykredit Group’s best financial results ever for the fifth year running, with a profit after tax for the year of DKK 12.4 billion. This confirms the fact that Nykredit has never been stronger. As we’re a customer-owned Group, our success benefits our customers, and in 2025, the Nykredit Group returned a total of DKK 3.0 billion to customers. That’s how it should be when our...

                To Nasdaq Copenhagen A/S4 February 2026Nykredit today announces the Annual Reports for 2025 of: Nykredit A/S, CVR no 12 71 92 48Nykredit Realkredit A/S, CVR no 12 71 92 80Nykredit Bank A/S, CVR no 10 51 96 08Totalkredit A/S, CVR no 21 83 22 78Spar Nord Bank A/S, CVR no 13 73 75 84                 Michael Rasmussen, Group Chief Executive, comments on the Nykredit Group’s financial results:Today, we can present the Nykredit Group’s best financial results ever for the fifth year running, with a profit after tax for the year of DKK 12.4 billion. This confirms the fact that Nykredit has never been stronger. As we’re a customer-owned Group, our success benefits our customers, and in 2025, the Nykredit Group returned a total of DKK 3.0 billion to customers. That’s how it should be when our...

Company announcement no. 01 Profit after tax of DKK 1,727 million and return on equity of 11.8% In terms of financial performance, 2025 delivered a profit after tax of DKK 1,727 million, corresponding to a return on equity after tax of 11.8% and a cost/income ratio of 59. The result is affected by the falling level of interest rates, with a lower return on the Bank’s substantial excess liquidity contributing to a reduction in net interest income. Moreover, there were total restructuring provisions of DKK 385 million and one-off costs relating to Nykredit’s acquisition of Spar Nord. Against this background, the Bank realised a profit before impairment charges which was DKK 710 million lower than in 2024. When compiling the profit for the year excluding items regarding Nykredit’s takeover, Spar Nord achieved a return on equity after tax...

SUDAN LITIGATION:  BNP PARIBAS WILL FILE ITS NOTICE OF APPEAL BY 9 FEBRUARY 2026 Paris, 4 February 2026 In its decision made public on 8 January 2026, the Court granted BNP Paribas’ request to proceed with its appeal. BNP Paribas welcomes the Court’s decision. The proceedings are therefore progressing as expected. BNP Paribas announces that the appeal will be filed by 9 February and that the Group is fully prepared and confident in the strength of its arguments. BNP Paribas will release its fourth quarter 2025 results and present its 2028 trajectory on Thursday, 5 February 2026.AttachmentSTATEMENT FROM BNP PARIBAS – SUDAN LITIGATION

Company Announcement No. 1164 Solid financial performance in Q4 and full-year 2025, and anticipated completion of the Schenker integration in 2026We delivered solid financial results in Q4 2025 and reported a full-year performance for 2025 in line with guidance, despite challenging and volatile market conditions throughout the year. In Q4 2025, the gross profit was DKK 19,119 million and EBIT before special items came to DKK 5,592 million, driven by the integration of Schenker. The integration continues to progress fast, and we now expect to complete the integration by end-2026. We continued the deleveraging plan, reducing net interest-bearing debt by more than DKK 7,000 million since completion of the transaction, based on a strong adjusted free cash flow of DKK 16,335 million in 2025. Diluted adjusted earnings per share was DKK 50.9...